Atossa Therapeutics Discusses Clinical Development for their Breast Cancer Programs

Planet MicroCap spoke with Dr. Steven Quay, President and CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS) via Zoom to discuss (Click the time stamp to jump to each answer, or watch it all):

[0:53] Quick overview and history of Atossa Therapeutics, Inc.
[2:19] Clinical development
[3:29] What differentiates Atossa Thearpeutics
[5:32] Dr. Quay's background
[7:18] Goals for 2024

For more information about Atossa Therapeutics, Inc., please visit: https://atossatherapeutics.com/

Atossa Therapeutics, Inc. will be presenting at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024. Register to participate here: https://planetmicrocapshowcase.com/

The interview may contain forward looking statements about Atossa Therapeutics, Inc. See Atossa Therapeutics, Inc.'s periodic filings with the Securities and Exchange Commission for more complete information.

About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. For more information, please visit www.atossatherapeutics.com.

Subscribe NOW to Planet MicroCap: http://bit.ly/1Q5Yfym

Get more Planet MicroCap:
Website: https://planetmicrocap.com/
Follow Planet MicroCap:   / planetmicrocap  
Like Planet MicroCap:   / planetmicrocap  
Follow Planet MicroCap on LinkedIn:   / plan.  .

Planet MicroCap is the Official YouTube Channel for the MicroCap markets by providing news, insights, education tools and expert commentary. Subscribe now to be notified when new CEO video interviews, WALL STREET VIEWS with investing experts and new episodes of the Planet MicroCap Podcast are LIVE!